Research
-
SAPHNELO approved in the US for subcutaneous self-administration for treatment of systemic lupus erythematosus (SLE)
.
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for treatment of people living with moderately to severely active autoantibody-positive systemic lupus erythematosus (SLE). The 120 mg dose of the therapy…
-
New World Lupus Federation Global Survey Finds 58% Know Very Little or Nothing About Lupus
.
Low familiarity and ongoing misconceptions underscore the need for increased education and broader visibility, building on more than a decade of progress On May 5, 2026, he World Lupus Federation (WLF)…
-
FDA approves Gazyva® (obinutuzumab), expanding therapeutic options for treatment of adults with lupus nephritis
.
FDA approval of Gazyva expands therapeutic options for lupus care The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults…
-
Clinical Trials in Lupus Research
.
Scientists, researchers, and volunteers all have a part to play in advancing clinical trial research. It’s thanks to the collaborative efforts of these groups that we have ways to…
-
NEWS: A Cancer therapy might offer hope for patients with lupus
.
From the New York Times by Nina Agrawal, Times health reporter Jennifer Le’s doctor ticked through a long checklist of head-to-toe symptoms as she examined Ms. Le in a…